(Q36117266)

12 August 2017

Serum markers lactate dehydrogenase and S100B predict independently disease outcome in melanoma patients with distant metastasis (English)

1 reference

12 August 2017

J Bauer

7

0 references

Ulrike Leiter

object named as

U Leiter

5

0 references

author name string

B Weide

1

1 reference

12 August 2017

M Elsässer

2

1 reference

12 August 2017

P Büttner

3

1 reference

12 August 2017

A Pflugfelder

4

1 reference

12 August 2017

T K Eigentler

6

1 reference

12 August 2017

M Witte

8

1 reference

12 August 2017

F Meier

9

1 reference

12 August 2017

C Garbe

10

1 reference

12 August 2017

language of work or name

English

0 references

publication date

10 July 2012

1 reference

British Journal of Cancer

12 August 2017

1 reference

12 August 2017

107

1 reference

12 August 2017

3

1 reference

12 August 2017

422-428

1 reference

https://scigraph.springernature.com/pub.10.1038/bjc.2012.306

12 August 2017

0 references

cites work

Does metastasectomy improve survival in patients with Stage IV melanoma? A cancer registry analysis of outcomes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3405231

Final version of 2009 AJCC melanoma staging and classification

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3405231

Prognostic significance of serum S100B protein in high-risk surgically resected melanoma patients participating in Intergroup Trial ECOG 1694.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3405231

A single-institution validation of the AJCC staging system for stage IV melanoma

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3405231

Evidence and interdisciplinary consensus-based German guidelines: surgical treatment and radiotherapy of melanoma

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3405231

Evidence and interdisciplinary consense-based German guidelines: diagnosis and surveillance of melanoma

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3405231

Complete metastasectomy in patients with stage IV metastatic melanoma

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3405231

NDR kinases regulate essential cell processes from yeast to humans

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3405231

Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3405231

S100: a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3405231

Gender and other survival predictors in patients with metastatic melanoma on Southwest Oncology Group trials

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3405231

Prognostic factors in metastatic melanoma: a pooled analysis of Eastern Cooperative Oncology Group trials

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3405231

Lung metastases from melanoma: when is surgical treatment warranted?

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3405231

Prognostic factors for survival of patients treated systemically for disseminated melanoma.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3405231

Surgical resection for melanoma metastatic to the gastrointestinal tract

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3405231

Predicting survival outcome of localized melanoma: an electronic prediction tool based on the AJCC Melanoma Database

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3405231

Elevated serum levels of the glial marker protein S100B are not specific for schizophrenia or mood disorders.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3405231

Long-term survival analysis in metastatic melanoma: serum S100B is an independent prognostic marker and superior to LDH.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3405231

Active secretion of S100B from astrocytes during metabolic stress.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3405231

Tyrosinase messenger RNA in peripheral blood is related to poor survival in patients with metastatic melanoma following interleukin-2-based immunotherapy.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3405231

Normal values of serum S-100B predict prolonged survival for stage IV melanoma patients

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3405231

Serum S100beta protein as a marker of disease activity in patients with malignant melanoma.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3405231

Does complete resection of melanoma metastatic to solid intra-abdominal organs improve survival?

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3405231

S100-Beta, melanoma-inhibiting activity, and lactate dehydrogenase discriminate progressive from nonprogressive American Joint Committee on Cancer stage IV melanoma

23 September 2018

1 reference

12 December 2020

Surgical therapy for distant metastases of malignant melanoma

1 reference

12 December 2020

Contemporary surgical treatment of advanced-stage melanoma

1 reference

12 December 2020

1 reference

12 December 2020

Regression analyses of prognostic factors in metastatic malignant melanoma

1 reference

12 December 2020

Prognostic factors in patients with metastatic malignant melanoma. A multivariate analysis

1 reference

12 December 2020

S-100 protein-negative malignant melanoma: fact or fiction? A light-microscopic and immunohistochemical study

1 reference

12 December 2020

Prognostic significance of serum S100B detection compared with routine blood parameters in advanced metastatic melanoma patients

1 reference

12 December 2020

Improvement of overall survival of patients with cutaneous melanoma in Germany, 1976-2001: which factors contributed?

1 reference

12 December 2020

Stage-IV melanoma and pulmonary metastases: factors predictive of survival

1 reference

12 December 2020

Identifiers

DOI

10.1038/BJC.2012.306

1 reference

Dimensions Publication ID

12 August 2017

0 references

1 reference

12 August 2017

PubMed publication ID

22782342

1 reference